Glipden-MV2

Glipden-Mv2 is a prescription combination medicine developed for the management of type 2 diabetes mellitus. It combines three antidiabetic medicines that work through different mechanisms to help manage blood glucose levels.

📋 COMPOSITION
Glimepiride 2mg + Metformin Hydrochloride (SR) 500mg + Voglibose 0.2mg

💊 DOSAGE FORM
Tablet

📦 PACKAGING TYPE
Blister

🗃️ PACKAGING
10×10

Description

Glipden-Mv2 is a prescription combination medicine developed for the management of type 2 diabetes mellitus. It combines three antidiabetic medicines that work through different mechanisms to help manage blood glucose levels.

This combination includes a sulfonylurea, a biguanide and an alpha-glucosidase inhibitor. Together, these medicines support blood glucose management when a healthcare professional considers combination therapy appropriate.

Glipden-Mv2 belongs to the Cardries Biotic range of Neuark Pharmaceutical and is supplied in blister packaging.

Therapeutic Segment

Diabetic Care Range | Oral Antidiabetic Medicines | Type 2 Diabetes Management

Uses of Glipden-Mv2

A healthcare professional may prescribe Glipden-Mv2 for:

  • Management of type 2 diabetes mellitus.
  • Supporting blood glucose control when a combination of antidiabetic medicines is required.
  • Helping manage blood glucose levels after meals.
  • Supporting an individualised diabetes treatment plan alongside diet and physical activity.

This medicine is not intended for the treatment of type 1 diabetes or diabetic ketoacidosis.

Key Features and Benefits

  • Triple-Drug Combination: Combines three antidiabetic medicines with different mechanisms of action.
  • Glimepiride: Helps the pancreas release insulin.
  • Metformin SR: Helps reduce glucose production in the liver and improves the body’s response to insulin.
  • Voglibose: Helps slow the digestion and absorption of carbohydrates in the intestine.
  • Blood Glucose Management: Supports overall blood glucose control when prescribed by a doctor.
  • Blister Packaging: Supplied in a 10 × 10 blister pack.

How It Works

Glipden-Mv2 contains three active medicines that help manage blood glucose through different actions.

Glimepiride belongs to the sulfonylurea group. It stimulates the pancreas to release insulin, which helps lower blood glucose levels.

Metformin SR is a sustained-release form of metformin. It reduces glucose production in the liver and helps the body use insulin more effectively. The sustained-release formulation allows the medicine to release gradually.

Voglibose belongs to the alpha-glucosidase inhibitor group. It slows the breakdown of certain carbohydrates in the intestine. As a result, it helps reduce the rise in blood glucose after meals.

Together, these medicines provide complementary actions for managing type 2 diabetes. However, the combination must be used under medical supervision.

Possible Side Effects

Some patients may experience side effects while taking Glipden-Mv2. These may include:

  • Low blood glucose (hypoglycaemia)
  • Nausea
  • Diarrhoea
  • Abdominal discomfort
  • Bloating or gas
  • Loss of appetite
  • Headache
  • Dizziness

Important: Glimepiride can cause low blood glucose, especially when meals are delayed, skipped or insufficient. Symptoms may include sweating, shaking, hunger, palpitations, confusion and dizziness.

Seek medical attention if side effects persist. Severe hypoglycaemia, unusual weakness, breathing difficulty or other serious symptoms require urgent medical care.

Important Safety Information

  • Use Glipden-Mv2 only on a doctor’s prescription.
  • Do not change the dose or stop treatment without medical advice.
  • Take the medicine according to the prescribed meal-related instructions.
  • Do not skip meals, as glimepiride may cause low blood glucose.
  • Monitor blood glucose regularly as advised by your doctor.
  • Inform your doctor if you have kidney disease, liver disease, heart failure or a history of severe hypoglycaemia.
  • Metformin may rarely cause a serious condition called lactic acidosis. Seek urgent medical attention for unusual muscle pain, severe weakness, breathing difficulty or unusual drowsiness.
  • Inform your doctor about alcohol consumption and all medicines or supplements you take.
  • Tell your healthcare professional before any surgery or contrast-dye imaging procedure.
  • This medicine is not suitable for every patient with diabetes. Your doctor will assess its suitability based on your health condition.

Dosage and Administration

Take Glipden-Mv2 exactly as prescribed by your doctor. The dose and timing depend on blood glucose levels, meal patterns, kidney function and individual treatment requirements.

Follow the instructions provided for the sustained-release formulation. Swallow the tablet as directed and do not crush or chew it unless the approved product instructions specifically allow this.

Take the medicine with the meal as advised by your doctor. Do not double the next dose if you miss one. Consult your healthcare professional for guidance.

Storage Instructions

  • Store in a cool and dry place.
  • Protect the tablets from moisture and direct sunlight.
  • Keep the tablets in their original blister packaging until use.
  • Keep out of reach of children.
  • Follow the storage instructions printed on the product packaging.

Reviews

There are no reviews yet.

Be the first to review “Glipden-MV2”

Your email address will not be published. Required fields are marked *